Small, E J
Higano, C S
Kantoff, P W
Whitmore, J B
Frohlich, M W
Petrylak, D P
Article History
Received: 14 February 2014
Revised: 24 April 2014
Accepted: 4 May 2014
First Online: 24 June 2014
Competing interests
: Dr Small is an Exelixis Advisory Committee Member, consultant to Dendreon at Advisory Board and Steering Committee meetings, and is a Principal Investigator on a trial involving Sipuleucel-T; Dr Higano is a consultant to Dendreon at Advisory Board and Steering Committee Meetings, and is a Principal Investigator on a clinical trial involving sipuleucel-T; Dr Kantoff is a consultant to Dendreon; Dr Whitmore and Dr Frohlich are Dendreon employees and own Dendreon stock; Dr Petrylak is a consultant to Dendreon and has received grant support from Dendreon.